Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Almila, Ulpu
DOB: 03-SEP-1993 (Age: 32)
Gender: female
Address:
Viru 51
94764 Tupenurme (Estonia)
ID: 9847-452473-7
Report
Date: 20-APR-2025
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
Emmaste Kliinik
92412 Hiiumaa vald (Estonia)
Specimen
Collected: 19-APR-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 19 Apr 2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 98.0 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.6 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.7 8.6 - 10.2 mg/dL
Sodium [Moles/volume] in Blood 141.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5 mmol/L
Chloride [Moles/volume] in Blood 111.0 H 111 - 101 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.8 24 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 188.9 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 148.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 107.4 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 51.9 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c levels (5.9–6.4%), indicating prediabetes with a trend toward worsening glycemic control, despite normal fasting glucose. Electrolytes, renal function, and lipid profile are within normal limits except for a mildly elevated chloride and borderline triglycerides. No acute abnormalities detected. Recommend further evaluation and management of glycemic status to prevent progression to diabetes.